United States· US:55150-320_41e11afb-5fa4-4212-889d-1092dbd0702a
SODIUM NITROPRUSSIDE
A medicinal product containing sodium nitroprusside, registered in United States by AuroMedics Pharma LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- SODIUM NITROPRUSSIDE
- Manufacturer
- AuroMedics Pharma LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1155150320011 VIAL, SINGLE-DOSE in 1 CARTON (55150-320-01) / 2 mL in 1 VIAL, SINGLE-DOSE
- ndc1155150-320-01
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Sodium nitroprusside in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomNitropress 50mg/2ml solution for infusion vialsImported (United States)
- CanadaNIPRIDEPFIZER CANADA ULC
- GermanyNiprussAltamedics Gmbh
- IcelandNiprussOresund Pharma ApS
- NorwayNiprussOresund Pharma ApS
- SwedenNipruss 60 mg Pulver till infusionsvätska, lösningØresund Pharma ApS
- FinlandNiprussOresund Pharma ApS (Øresund Pharma)
- SwitzerlandNipruss 60 mg, Pulver zur Herstellung einer InfusionslösungOspedalia AG
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Austria · Nipruss, Nitroprussid-Natrium Aftpharm
- Germany · Nipruss, Nitroprussid-Natrium Aftpharm
- Denmark · Nipruss
- Spain · Nitroprussiat Fides
- Finland · Nipruss
- United Kingdom (Northern Ireland) · Sodium Nitroprusside Aft Uk
- Hungary · Nipruss
- Iceland · Nipruss
- Netherlands · Nipruss
- Norway · Nipruss
- Sweden · Nipruss
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fd756de0-b2b7-425d-ba05-66a2ffdaed67 GET /v1/drugs/fd756de0-b2b7-425d-ba05-66a2ffdaed67?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "50",
"substance": "SODIUM NITROPRUSSIDE",
"productndc": "55150-320",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/2mL",
"application_number": "ANDA211934",
"marketing_category": "ANDA"
}See everything about sodium nitroprusside.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.